October 19, 2011

Abbott on Wednesday morning announced plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.

October 19, 2011

Armada Health Care announced that its annual Armada Specialty Pharmacy Summit will feature Karl Rove and Robert Gibbs as keynote speakers.

October 18, 2011

The Healthcare Distribution Management Association on Tuesday named six new members to its board of directors.

October 18, 2011

Teva Pharmaceutical Industries has completed its acquisition of another drug maker, following clearance from the Federal Trade Commission.

October 17, 2011

Archimedes Pharma has launched a new drug for breakthrough cancer pain, the drug maker said Monday.

October 14, 2011

The Food and Drug Adminsitration has approved a drug made by ApoPharma for a complication resulting from treatments for a genetic condition that causes anemia, the agency said Friday.

October 12, 2011

A National Institutes of Health study published Tuesday in the Journal of the American Medical Association established a link between vitamin E supplementation and prostate cancer.

October 12, 2011

Multiple sclerosis patients treated with a drug made by Teva Pharmaceutical Industries showed a "significant" reduction in their loss of brain volume, according to a new study.

October 11, 2011

The Food and Drug Administration has accepted the first regulatory approval application for a generic version of a cancer drug made by Eisai.

October 11, 2011

A drug maker that focuses on treatments for hemophilia has named a new CEO.

October 11, 2011

Walgreens on Tuesday named Jeffrey Kang and Mike Ellis to its pharmacy, health and wellness division.

October 10, 2011

Giant Food Stores is marking National Breast Cancer Awareness Month by donating more than $25,000 to organizations that address the disease, the Royal Ahold-owned supermarket chain said.

October 10, 2011

Business Leader Magazine has given its 2011 Movers & Shakers Award to Nancy McFarlane, president of specialty pharmacy provider MedPro Rx, the company said.

October 7, 2011

A growing number of people with Medicare are using free preventive services provided by the Affordable Care Act, the Centers for Medicare and Medicaid Services said.

October 6, 2011

Gilead Sciences has signed an agreement with Boehringer Ingelheim to gain exclusive worldwide rights to research, develop and commercialize BI's novel anti-retroviral compounds.

October 6, 2011

German drug maker Merck KGaA will collaborate with Japanese drug maker Ono Pharmaceutical to develop oral therapies for cancer and multiple sclerosis, Merck KGaA said.

October 6, 2011

A drug under investigation by Sanofi for multiple sclerosis improved several measures of disease activity in patients, according to results of a late-stage clinical trial.

October 6, 2011

Genomics has the potential to revolutionize the treatment of cancer and the drug industry, and the New York Pharma Forum is sponsoring a symposium on the subject in December.

October 5, 2011

The Food and Drug Administration has accepted a regulatory approval application from Merck and Ariad Pharmaceuticals for a new drug to treat soft-tissue and bone cancers, the drug makers said Wednesday.

October 3, 2011

Bristol-Myers Squibb will present 22 study abstracts next month at the 62nd annual meeting of the American Association for the Study of Liver Diseases in San Francisco, the company said.

October 3, 2011

Pharmacy benefit manager Express Scripts has launched a suite of services for drug makers through HealthBridge Pharma & Biotech to provide a single-solution approach to patient care.

September 29, 2011

The American Pharmacists Association is marking Pain Awareness Month by encouraging patients to talk with their pharmacists about pain and pain medications they're taking.

September 29, 2011

A "vast majority" of employers don't know how much they're spending on specialty drugs through their medical or pharmacy plans, according to a new survey by the Midwest Business Group on Health.

September 28, 2011

Sagent Pharmaceuticals has launched its new chemotherapy drug.